|
CEP290 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.89419957286452E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7168999999484E-07 |
| Normal-vs-Stage2 |
5.392600E-04 |
| Normal-vs-Stage3 |
3.46009999996344E-06 |
| Normal-vs-Stage4 |
1.19239999996079E-06 |
| Stage1-vs-Stage2 |
2.967600E-01 |
| Stage1-vs-Stage3 |
3.997000E-01 |
| Stage1-vs-Stage4 |
3.121400E-01 |
| Stage2-vs-Stage3 |
6.405600E-01 |
| Stage2-vs-Stage4 |
7.149400E-01 |
| Stage3-vs-Stage4 |
9.043000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.82919995501175E-09 |
| Normal-vs-AfricanAmerican |
1.52342999999444E-05 |
| Normal-vs-Asian |
1.095770E-01 |
| Caucasian-vs-AfricanAmerican |
9.493600E-02 |
| Caucasian-vs-Asian |
2.953400E-01 |
| AfricanAmerican-vs-Asian |
4.576600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.88230000054102E-08 |
| Normal-vs-Female |
6.10290040725658E-10 |
| Male-vs-Female |
6.594200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.938280E-02 |
| Normal-vs-Age(41-60Yrs) |
1.12300002630406E-09 |
| Normal-vs-Age(61-80Yrs) |
9.79130000411388E-08 |
| Normal-vs-Age(81-100Yrs) |
3.778300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.076200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.412200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.954200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.141200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.871220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.012200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.03500000000023E-05 |
| Normal-vs-Grade 2 |
3.3425999745873E-09 |
| Normal-vs-Grade 3 |
1.18260000003811E-06 |
| Normal-vs-Grade 4 |
2.25839999999922E-05 |
| Grade 1-vs-Grade 2 |
3.690400E-01 |
| Grade 1-vs-Grade 3 |
1.961040E-01 |
| Grade 1-vs-Grade 4 |
2.253600E-01 |
| Grade 2-vs-Grade 3 |
1.302020E-01 |
| Grade 2-vs-Grade 4 |
3.883600E-01 |
| Grade 3-vs-Grade 4 |
7.034200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.46740000442847E-08 |
| Normal-vs-ccB subtype |
1.55040000004991E-06 |
| ccA subtype-vs-ccB subtype |
7.826400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.06040000511254E-08 |
| Normal-vs-N1 |
5.437700E-03 |
| N0-vs-N1 |
8.201400E-01 |
|
|
